{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:20:43Z","timestamp":1767370843090,"version":"3.48.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.7759\/cureus.100625","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:11:42Z","timestamp":1767370302000},"source":"Crossref","is-referenced-by-count":0,"title":["Detection of Subclinical Diabetic Neuropathy in Type 2 Diabetes: A Study of Nerve Conduction Parameters and Their Associations With Metabolic and Demographic Factors"],"prefix":"10.7759","author":[{"given":"Suyash","family":"Litoriya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahebrao Kishanrao","family":"Sadawarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0316-1","article-title":"Benefit of lifestyle-based type 2 diabetes mellitus prevention is influenced by prediabetes phenotype","volume":"16","author":"Campbell MD","year":"2020","unstructured":"Campbell MD, Sathish T, Zimmet PZ, et al.. Benefit of lifestyle-based type 2 diabetes mellitus prevention is influenced by prediabetes phenotype. Nat Rev Endocrinol. 2020, 16:395-400. 10.1038\/s41574-019-0316-1","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun H","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al.. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022, 183:109119. 10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho NH","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018, 138:271-81. 10.1016\/j.diabres.2018.02.023","journal-title":"Diabetes Res Clin Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014, 37:S81-90. 10.2337\/dc14-S081","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui R","year":"2017","unstructured":"Pop-Busui R, Boulton AJ, Feldman EL, et al.. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017, 40:136-54. 10.2337\/dc16-2042","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton AJ","year":"2005","unstructured":"Boulton AJ, Vinik AI, Arezzo JC, et al.. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005, 28:956-62. 10.2337\/diacare.28.4.956","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks CW","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019, 19:86. 10.1007\/s11892-019-1212-8","journal-title":"Curr Diab Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.04.001","article-title":"Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy","volume":"40","author":"Iqbal Z","year":"2018","unstructured":"Iqbal Z, Azmi S, Yadav R, et al.. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018, 40:828-49. 10.1016\/j.clinthera.2018.04.001","journal-title":"Clin Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000358728","article-title":"Diabetic neuropathies: diagnosis and management","volume":"98","author":"Deli G","year":"2013","unstructured":"Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013, 98:267-80. 10.1159\/000358728","journal-title":"Neuroendocrinology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1296::AID-MUS12>3.0.CO;2-1","article-title":"F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus","volume":"20","author":"Andersen H","year":"1997","unstructured":"Andersen H, St\u00e5lberg E, Falck B. F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve. 1997, 20:1296-302. 10.1002\/(SICI)1097-4598(199710)20:10&lt;1296::AID-MUS12&gt;3.0.CO;2-1","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0921-884X(96)95635-0","article-title":"F-waves in clinical neurophysiology: a review, methodological issues and overall value in peripheral neuropathies","volume":"101","author":"Panayiotopoulos CP","year":"1996","unstructured":"Panayiotopoulos CP, Chroni E. F-waves in clinical neurophysiology: a review, methodological issues and overall value in peripheral neuropathies. Electroencephalogr Clin Neurophysiol. 1996, 101:365-74. 10.1016\/S0921-884X(96)95635-0","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"ref12","article-title":"A study on the utility of nerve conduction studies in type 2 diabetes mellitus","volume":"5","author":"Kanavi RS","year":"2011","unstructured":"Kanavi RS, Srinivasa AK, Vedavathi KJ, Venkatesh G. A study on the utility of nerve conduction studies in type 2 diabetes mellitus. J Clin Diagn Res. 2011, 5:529-31.","journal-title":"J Clin Diagn Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5455\/njppp.2018.8.0826828082018","article-title":"Nerve conduction study in neurologically asymptomatic diabetic patients and correlation with glycosylated hemoglobin and duration of diabetes","volume":"8","author":"Agarwal S","year":"2018","unstructured":"Agarwal S, Lukhmana S, Kahlon N, Malik P, Nandini H. Nerve conduction study in neurologically asymptomatic diabetic patients and correlation with glycosylated hemoglobin and duration of diabetes. Natl J Physiol Pharm Pharmacol. 2018, 8:1533-8. 10.5455\/njppp.2018.8.0826828082018","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.31782\/IJCRR.2019.11302","article-title":"A study on effects of HbA1c levels on nerve conduction velocity in type 2 diabetes mellitus patients","volume":"11","author":"Masood A","year":"2019","unstructured":"Masood A, Rizvi SAA, Siddiqi SS, Ziauddin M. A study on effects of HbA1c levels on nerve conduction velocity in type 2 diabetes mellitus patients. Int J Curr Res Rev. 2019, 11:6-8. 10.31782\/IJCRR.2019.11302","journal-title":"Int J Curr Res Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5535\/arm.2016.40.2.263","article-title":"Correlation between the severity of diabetic peripheral polyneuropathy and glycosylated hemoglobin levels: a quantitative study","volume":"40","author":"Lee WJ","year":"2016","unstructured":"Lee WJ, Jang S, Lee SH, Lee HS. Correlation between the severity of diabetic peripheral polyneuropathy and glycosylated hemoglobin levels: a quantitative study. Ann Rehabil Med. 2016, 40:263-70. 10.5535\/arm.2016.40.2.263","journal-title":"Ann Rehabil Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212574","article-title":"The risk factors for diabetic peripheral neuropathy: a meta-analysis","volume":"14","author":"Liu X","year":"2019","unstructured":"Liu X, Xu Y, An M, Zeng Q. The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS One. 2019, 14:e0212574. 10.1371\/journal.pone.0212574","journal-title":"PLoS One"},{"key":"ref17","article-title":"Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry","volume":"13","author":"Oguejiofor OC","year":"2010","unstructured":"Oguejiofor OC, Odenigbo CU, Oguejiofor CB. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry. Niger J Clin Pract. 2010, 13:240-7.","journal-title":"Niger J Clin Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2020\/44524.14063","article-title":"Association of nerve conduction velocity with total body fat mass and body mass index in type 2 diabetes mellitus","volume":"14","author":"Rahman F","year":"2020","unstructured":"Rahman F, Rahman A. Association of nerve conduction velocity with total body fat mass and body mass index in type 2 diabetes mellitus. J Clin Diagn Res. 2020, 14:1-5. 10.7860\/JCDR\/2020\/44524.14063","journal-title":"J Clin Diagn Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05318","article-title":"Sensory nerve conduction study of median ulnar and radial nerves in type 2 diabetic individuals in the age group 40-80 years","volume":"6","author":"Sepat P","year":"2020","unstructured":"Sepat P, Wasnik S. Sensory nerve conduction study of median ulnar and radial nerves in type 2 diabetic individuals in the age group 40-80 years. Heliyon. 2020, 6:e05318. 10.1016\/j.heliyon.2020.e05318","journal-title":"Heliyon"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman EL","year":"1994","unstructured":"Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994, 17:1281-9. 10.2337\/diacare.17.11.1281","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0850","article-title":"Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?","volume":"30","author":"Albers JW","year":"2007","unstructured":"Albers JW, Herman WH, Pop-Busui R, Martin CL, Cleary P, Waberski B. Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?. Diabetes Care. 2007, 30:2613-8. 10.2337\/dc07-0850","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2337\/diab.38.11.1456","article-title":"Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study","volume":"38","author":"Maser RE","year":"1989","unstructured":"Maser RE, Steenkiste AR, Dorman JS, et al.. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study. Diabetes. 1989, 38:1456-61. 10.2337\/diab.38.11.1456","journal-title":"Diabetes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.41.6.799","article-title":"The Rochester diabetic neuropathy study: design, criteria for types of neuropathy, selection bias and reproducibility of neuropathic tests","volume":"41","author":"Dyck PJ","year":"1991","unstructured":"Dyck PJ, Kratz KM, Lehman KA, et al.. The Rochester diabetic neuropathy study: design, criteria for types of neuropathy, selection bias and reproducibility of neuropathic tests. Neurology. 1991, 41:799-807. 10.1212\/wnl.41.6.799","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron NE","year":"2001","unstructured":"Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001, 44:1973-88. 10.1007\/s001250100001","journal-title":"Diabetologia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2239","article-title":"Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy","volume":"28","author":"Tesfaye S","year":"2012","unstructured":"Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012, 28:8-14. 10.1002\/dmrr.2239","journal-title":"Diabetes Metab Res Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2013.12.005","article-title":"Diabetic peripheral neuropathy: current perspective and future directions","volume":"80","author":"Singh R","year":"2014","unstructured":"Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res. 2014, 80:21-35. 10.1016\/j.phrs.2013.12.005","journal-title":"Pharmacol Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton IM","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, et al.. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321:405-12. 10.1136\/bmj.321.7258.405","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2439691","article-title":"The relationship between peripheral nerve conduction velocity and ophthalmological findings in type 2 diabetes patients with early diabetic retinopathy","volume":"2018","author":"Ito A","year":"2018","unstructured":"Ito A, Kunikata H, Yasuda M, et al.. The relationship between peripheral nerve conduction velocity and ophthalmological findings in type 2 diabetes patients with early diabetic retinopathy. J Ophthalmol. 2018, 2018:2439691. 10.1155\/2018\/2439691","journal-title":"J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446357-detection-of-subclinical-diabetic-neuropathy-in-type-2-diabetes-a-study-of-nerve-conduction-parameters-and-their-associations-with-metabolic-and-demographic-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:11:43Z","timestamp":1767370303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446357-detection-of-subclinical-diabetic-neuropathy-in-type-2-diabetes-a-study-of-nerve-conduction-parameters-and-their-associations-with-metabolic-and-demographic-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.100625","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}